EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ECSIT‐X4 is Required for Preventing Pressure Overload‐Induced Cardiac Hypertrophy via Regulating Mitochondrial STAT3

Xia Lu, Tingting Tong, Haoliang Sun, Yi Chen, Yongfeng Shao, Pengxi Shi, Linli Que, Li Liu, Guoqing Zhu, Qi Chen, Chuanfu Li, Jiantao Li und 2 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202414358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xia Lu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine,…. Hauptthemen laut MEDLINE: Cardiomegaly, STAT3 Transcription Factor, Mitochondria, Mitochondria, Heart. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction is a key factor in exacerbating pressure overload‐induced cardiac hypertrophy and is linked to increased morbidity and mortality. ECSIT, a crucial adaptor for inflammation and mitochondrial function, has been reported to express multiple transcripts in various species and tissues, leading to distinct protein isoforms with diverse subcellular localizations and functions. However, whether an unknown ECSIT isoform exists in cardiac cells and its potential role in regulating mitochondrial function and pathological cardiac hypertrophy has remained unclear. This study identified a 42‐kDa ECSIT isoform encoded by the transcript variant Ecsit‐X4, which is highly expressed in the mitochondria of adult cardiomyocytes but down‐regulated in hypertrophic human heart samples and TAC‐treated mouse hearts. AAV9‐mediated Ecsit‐X4 gene therapy, administered either before or after TAC surgery, significantly attenuated cardiac hypertrophy. Cardiomyocyte‐specific Ecsit deficiency worsened TAC‐induced cardiac hypertrophy, while Ecsit‐X4 compensation independently rescued hypertrophic phenotypes in Ecsit cKO mice. Mechanistically, ECSIT‐X4 localized to the mitochondria and interacted with STAT3, leading to increased STAT3 levels and enhanced serine 727 phosphorylation in cardiomyocyte mitochondria, thereby promoting strong mitochondrial bioenergetics. This study identified a novel transcript variant of ECSIT localized in the mitochondria of adult cardiomyocytes and highlights its potential as a therapeutic target for heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomegalySTAT3 Transcription FactorMitochondriaMitochondria, HeartAnimalsMiceHumansMyocytes, CardiacMaleMice, KnockoutMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

ECSIT‐X4STAT3cardiac hypertrophymitochondria

Substanzen

STAT3 Transcription FactorStat3 protein, mouse

Autor:innen und Institutionen

  • Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, School of Basic Medical Sciences, Nanjing Medical University, Nanjing…
  • Department of Cardiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China.
  • Department of Geriatrics, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China.
  • Department of Surgery, East Tennessee State University, Campus Box 70575, Johnson City, TN, 37614-0575, USA.
  • Department of Immunology, Key Laboratory of Immunological Environment and Disease, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.

ORCID-Profile: Shuo Yang, Yuehua Li

Förderung

  • National Natural Science Foundation of China
  • Collaborative Innovation Center for Cardiovascular Disease Translational Medicine

Zitieren

APA

Lu, X., Tong, T., Sun, H., Chen, Y., Shao, Y., Shi, P., Que, L., Liu, L., Zhu, G., Chen, Q., Li, C., Li, J., Yang, S., & Li, Y. (2025). ECSIT‐X4 is Required for Preventing Pressure Overload‐Induced Cardiac Hypertrophy via Regulating Mitochondrial STAT3. Advanced Science. https://doi.org/10.1002/advs.202414358

Vancouver

Lu X, Tong T, Sun H, Chen Y, Shao Y, Shi P, et al. ECSIT‐X4 is Required for Preventing Pressure Overload‐Induced Cardiac Hypertrophy via Regulating Mitochondrial STAT3. Advanced Science. 2025. doi:10.1002/advs.202414358

BibTeX
@article{Lu2025,
  author = {Lu, Xia and Tong, Tingting and Sun, Haoliang and Chen, Yi and Shao, Yongfeng and Shi, Pengxi and Que, Linli and Liu, Li and Zhu, Guoqing and Chen, Qi and Li, Chuanfu and Li, Jiantao and Yang, Shuo and Li, Yuehua},
  title = {ECSIT‐X4 is Required for Preventing Pressure Overload‐Induced Cardiac Hypertrophy via Regulating Mitochondrial STAT3},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202414358}
}
Kostenlos starten →